Press release
Antibody Therapeutics Market to Reach $479.0 Billion by 2028 Driven by Oncology Demand and Biologic Innovation
According to MarketsandMarkets Trademark , the global antibody therapeutics market [https://www.marketsandmarkets.com/Market-Reports/antibody-therapeutics-market-178852478.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] is projected to grow from USD 247.3 billion in 2023 to USD 479.0 billion by 2028, registering a robust CAGR of 14.1%. This significant expansion reflects accelerating innovation in antibody engineering, increasing demand for targeted therapies, and a rapidly growing clinical pipeline. As biologics continue to redefine modern medicine, how are antibody therapeutics shaping the future of disease treatment?
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=178852478 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=178852478&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Browse
* 313 Market Data Tables
* 51 Figures
* 306 Pages and in-depth TOC on " Antibody Therapeutics Market - Global Forecast to 2028".
What is driving this remarkable market growth?
Continuous advancements in antibody engineering technologies are enabling the development of highly specific and effective therapies. These innovations, combined with increasing investments in research and development, are enhancing treatment outcomes across multiple disease areas, particularly in oncology and autoimmune disorders.
Why are monoclonal antibodies leading the format segment?
Monoclonal antibodies (mAbs) represent the fastest-growing segment due to their high target specificity and expanding pipeline. Their ability to precisely target disease-causing cells while minimizing off-target effects has made them a cornerstone of modern therapeutics, particularly in complex and chronic conditions.
How is oncology influencing market expansion?
The oncology segment is emerging as the fastest-growing disease area within the antibody therapeutics market. A strong pipeline of antibody-based cancer therapies, coupled with rising global cancer incidence, is driving significant investment and innovation in this segment. These therapies are increasingly being adopted as frontline and combination treatments, transforming cancer care paradigms.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=178852478 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=178852478&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Regional Insights:
What makes Europe a key growth hub? Europe represents the second-largest market for antibody therapeutics, supported by strong research infrastructure and advancements in biologics development. Countries such as Germany, the UK, and France are at the forefront of innovation, benefiting from the presence of leading pharmaceutical companies and robust regulatory frameworks that support therapeutic advancements.
Market Insights:
The antibody therapeutics market is highly consolidated, with major players focusing on strategic collaborations, product innovation, and pipeline expansion. Key companies include F. Hoffmann-La Roche Ltd. (Switzerland), AbbVie Inc. (US), Johnson & Johnson (US), Bristol-Myers Squibb (US), AstraZeneca (UK), Sanofi (France), Regeneron Pharmaceuticals, Inc. (US), Novartis AG (Switzerland), Amgen, Inc. (US), Biogen Inc. (US), and Merck KGaA (Germany). These organizations are actively shaping the competitive landscape through innovation and global expansion strategies.
As antibody therapeutics continue to revolutionize treatment across disease areas, stakeholders must align with emerging trends in biologics, precision medicine, and oncology innovation. To access detailed market insights, competitive analysis, and strategic opportunities, explore the full report today.
Related Reports:
Monoclonal Antibody Therapeutics Market [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=115323820&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] - Global Forecast to 2029
Hematology Analyzers and Reagents Market [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153222146&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] - Global Forecast to 2029
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=antibody-therapeutics-market-to-reach-4790-billion-by-2028-driven-by-oncology-demand-and-biologic-innovation]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/antibody-therapeutics-market-178852478.html
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antibody Therapeutics Market to Reach $479.0 Billion by 2028 Driven by Oncology Demand and Biologic Innovation here
News-ID: 4488148 • Views: …
More Releases from ABNewswire
Kartoon Studios (NYSE American: TOON) Surges on Volume as Media Consolidation Ac …
Kartoon Studios (NYSE: TOON) is gaining significant investor attention as momentum builds across the media sector following reports that investors have approved a major transaction involving Warner Bros. Discovery (NASDAQ: WBD) and Paramount Skydance (NASDAQ: PSKY), intensifying consolidation across streaming and entertainment markets.
Against this backdrop, TOON has begun to stand out as a smaller-cap player positioned within the evolving content ecosystem. The stock has experienced a notable surge in trading…
Latest Research on Boat Type in the Electric Boats Market by MarketsandMarkets T …
The Electric Boats Market is projected to grow from USD 4.39 Billion in 2026 to USD 10.60 Billion in 2031 at a CAGR of 19.2%.
The report "Electric Boats Market [https://www.marketsandmarkets.com/Market-Reports/electric-boat-market-260762373.html?utm_source=abnewswire.com&utm_medium=PaidPR&utm_campaign=electricboatmarket]by Boat Type (Cruising, Speedboat, Fishing, Passenger, Workboat, Patrol, and Combat), Power Source (Battery, Solar, and Hybrid), Boat Power (30 kW), Hull Type, Mode of Operation, Boat Size, and Region - Global Forecast to 2031" The electric boats market is projected…
Compounding Pharmacy Market to Reach $19.41 Billion by 2030 Driven by Drug Short …
Compounding Pharmacy Market by Product (Oral, Topical, Parenteral), Compounding Type (Ingredient Alteration, Dosage Alteration), Therapeutic Application (Pain Management, HRT), Sterility (Sterile), End User (Pediatric, Adult) - Global forecast to 2030
According to MarketsandMarkets Trademark , the global compounding pharmacy market [https://www.marketsandmarkets.com/Market-Reports/compounding-pharmacy-market-57885999.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] is projected to grow from USD 14.72 billion in 2025 to USD 19.41 billion by 2030, at a CAGR of 5.7%. Persistent drug shortages across major markets and stricter enforcement…
Customer Experience Management Market Leading Companies, Size, Share, Growth Fac …
Customer Experience Management (CEM) Market by Offering (Solutions, Services), Touchpoint, Deployment Type, Organization Size, Vertical (Travel & Hospitality, BFSI, Retail, Healthcare, IT & Telecom) and Region - Global Forecast to 2028.
The Customer Experience Management Market [https://www.marketsandmarkets.com/Market-Reports/customer-experience-management-cem-market-543.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=customer-experience-management-cem-market] is expected to grow at a compound annual growth rate (CAGR) of 12.2% from its estimated value of USD 11.4 billion in 2023 to USD 20.4 billion by 2028. The market for customer experience…
More Releases for Antibody
OBP2A Antibody Market Thrives on Technological Innovations in Antibody Productio …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global OBP2A Antibody Market- (By Type (Polyclonal Antibodies, and Monoclonal Antibodies; By Application-(Enzyme Linked Immunosorbent Assay, Immunohistochemistry, & Western Blot)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global OBP2A Antibody Market is valued at US$ 102.9 Mn in 2023, and it is expected to…
Evolving Market Trends In The Antibody Drug Conjugates Industry: Regulation On A …
The Antibody Drug Conjugates Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Antibody Drug Conjugates Market Size During the Forecast Period?
The market size for antibody drug conjugates has experienced rapid expansion in the past few years. It's projected to rise from…
TIGIT Antibody Clinical Trials FDA Approval Market Size Anti TGIT Antibody Sales …
Anti TIGIT Antibodies Clinical Trials & Market Opportunity Outlook 2028 Report Highlights:
• Anti TIGIT Antibodies In Clinical Trials: > 50 Antibodies
• First Anti TIGIT Antibody To Get Approval Within Next 5 Years
• Global Anti TIGIT Antibodies Clinical Pipeline Insight By Company, Indication and Phase
• Insight On More Than 50 Anti TIGIT Antibodies In Clinical Trials
• Anti TIGIT Antibodies Market Trends by Indication & Country
• Global Anti TIGIT Antibodies Market Dynamics
Download Report:
https://www.kuickresearch.com/report-anti-tigit-antibody-anti-tigit-antibodies-fda-approved-tigit-antibody-tigit-inhibitors-tigit-drugs-approved-tigit-expression-tigit-ligand-tigit-gene
In recent years, the global…
Mammalian Polyclonal IgG Antibody Market, Mammalian Polyclonal IgG Antibody Mark …
"According to the research report, the global inspection machines market was valued at USD 845.21 million in 2022 and is expected to reach USD 1,437.59 million by 2032, to grow at a CAGR of 5.5% during the forecast period."
Request Our Free Sample Report for Inspection Machines Market Insights and Emerging Trends @ https://www.polarismarketresearch.com/industry-analysis/inspection-machines-market/request-for-sample
Report Overview
Polaris Market Research, a leading global market research and consulting company, has recently published its latest report…
Global Combination Antibody Therapy Market 2022: Antibody/Antibody Combination S …
The combination antibody therapy market is expected to experience significant growth in the coming years. Combination antibody therapy involves the use of two or more monoclonal antibodies (mAbs) in combination to treat various diseases, such as cancer, autoimmune disorders, and infectious diseases.
Request For Free Sample Report of "Combination Antibody Therapy Market"@ https://www.persistencemarketresearch.com/samples/11740
Combination antibody therapy has several potential benefits over single-agent therapies, including increased efficacy, improved patient outcomes, and reduced toxicity.…
Global Combination Antibody Therapy Market 2022: Antibody/Antibody Combination S …
Combination antibody therapy involves the use of two or more antibodies to target and treat a specific disease or condition. This type of therapy is often used in cancer treatment, as it can be more effective at targeting and killing cancer cells than single-antibody therapies. Combination antibody therapy can also be used to treat a range of other diseases and conditions, including autoimmune diseases, infectious diseases, and allergic conditions.
Request For…
